These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 16470150)

  • 41. Cardiac allograft vasculopathy: current knowledge and future direction.
    Colvin-Adams M; Agnihotri A
    Clin Transplant; 2011; 25(2):175-84. PubMed ID: 21457328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factor analysis in pediatric heart transplantation.
    Tjang YS; Stenlund H; Tenderich G; Hornik L; Bairaktaris A; Körfer R
    J Heart Lung Transplant; 2008 Apr; 27(4):408-15. PubMed ID: 18374877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac surgery after heart transplantation: coronary artery bypass grafting and heart valve replacement.
    Coskun KO; Coskun ST; El Arousy M; Amin Parsa M; Schulz U; Deyerling W; Tenderich G; Bairaktaris A; Koerfer R
    Heart Surg Forum; 2007; 10(2):E110-4. PubMed ID: 17597032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac transplantation in Hawaii.
    Moreno-Cabral CE; Nakaahiki JH
    Hawaii Med J; 1994 Mar; 53(3):80-4. PubMed ID: 8005782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heart transplantation 1987--2007: 20 years' experience at Chulalongkorn hospital.
    Ongcharit P; Wongkietkachorn K; Sritangsirikul S; Namchaisiri J; Singhatanatkit S; Luengtaviboon K; Benjacholamas V; Ongcharit C
    Transplant Proc; 2008 Oct; 40(8):2591-3. PubMed ID: 18929809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
    Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
    J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac transplantation: a review.
    Oaks TE; Wallwork J
    Br J Biomed Sci; 1993 Sep; 50(3):200-11. PubMed ID: 8241836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors?
    Wehner JR; Baldwin WM
    Curr Opin Organ Transplant; 2010 Oct; 15(5):639-44. PubMed ID: 20689436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment and prophylaxis of cardiac allograft vasculopathy.
    Wang SS
    Transplant Proc; 2008 Oct; 40(8):2609-10. PubMed ID: 18929815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Coronary lesions of a cardiac transplant. (Chronic cardiac rejection). Study of 15 retransplantations].
    Loire R; Tabib A; Dureau G; Boissonnat P
    Ann Pathol; 1991; 11(5-6):334-41. PubMed ID: 1804153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The central role of the endothelium in graft coronary vasculopathy and heart transplantation.
    Perrault LP; Carrier M
    Can J Cardiol; 2005 Oct; 21(12):1077-83. PubMed ID: 16234893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The University of California at Los Angeles heart transplantation experience.
    Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
    Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac transplantation and resistance artery myogenic tone.
    Moien-Afshari F; Skarsgard PL; McManus BM; Laher I
    Can J Physiol Pharmacol; 2004 Oct; 82(10):840-8. PubMed ID: 15573144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term results after systematic off-pump coronary artery bypass graft surgery in 1000 consecutive patients.
    El-Hamamsy I; Cartier R; Demers P; Bouchard D; Pellerin M
    Circulation; 2006 Jul; 114(1 Suppl):I486-91. PubMed ID: 16820623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual origin of intimal cells in cardiac-allograft arteriosclerosis.
    Kennedy LJ; Weissman IL
    N Engl J Med; 1971 Oct; 285(16):884-7. PubMed ID: 4939537
    [No Abstract]   [Full Text] [Related]  

  • 57. Heart transplantation for end-stage valvular disease: indications and results.
    Pavie A
    Curr Opin Cardiol; 2006 Mar; 21(2):100-5. PubMed ID: 16470144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse outcomes from the use of older donor hearts in cardiac transplant recipients: the pros and cons of expanded donor criteria.
    Eisen HJ
    J Am Coll Cardiol; 2004 May; 43(9):1562-4. PubMed ID: 15120812
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiac transplantation in children.
    Zuberbuhler JR; Fricker FJ; Griffith BP
    Cardiol Clin; 1989 May; 7(2):411-8. PubMed ID: 2659182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Coronary endothelial dysfunction and graft atheromatosis following heart transplantation].
    Vassalli G
    Schweiz Med Wochenschr; 1995 Oct; 125(41):1923-30. PubMed ID: 7481650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.